Asset management

The combined fund, expected to finalize later this year, will retain the Windsor name and continue to focus on large- and mid-cap value stocks.

Even some of the industry’s cheapest products “may be overpriced” in that they’re “mirroring a passive index,” an expert says.

As policymakers fear a deflation spiral reminiscent of the Great Depression, contrarians wonder if ultra-loose monetary policies can inspire growth.

It’s the latest example of how firms who spent the past decade battling low yields are now raising cash to seize on deep discounts from the coronavirus.

This year’s honorees discuss how their firms are coping with the coronavirus pandemic and how this period may reshape the industry.

Hedge fund managers, market academics and risk experts are channeling their data-mining smarts to the world of clinical sciences.

With the industry facing ridicule for high fees and low returns, clients have pulled a net $33 billion from the industry in the first quarter, the most over a decade.

Firms "pulled in many directions" in recent years can find their way with the right technology, Jemstep CEO Simon Roy says in an episode of Financial Planning's Invest Podcast.

CEO Larry Fink announced a new focus on ESG in January, however the coronavirus has pushed a separate set of urgent issues into the forefront.

The firm’s chief investment officer spent as much as a third of that on high-yield funds, according to people with knowledge of the matter.